# Orchid Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orchid-biosciences

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: www.orchidhealth.com
- Total disclosed funding: $4.5M
- Latest round: Seed (Apr 7, 2021)
- Investors on record: 13

## About

Founded in 2019 and based in California, US, Orchid Biosciences, Inc. operates as a developer of medical software to detecting rare genetic disorders. The company was founded by CEO Noor Siddiqui. In April 2021, Orchid Biosciences raised USD 4.5 million in seed funding from Refactor Capital, Village Global, Day One Ventures, Olive Capital, Boom Capital, and other investors.

Orchid detects couple's future child will be at elevated or normal genetic risk to other diseases. The company allows couples to discover their future child's risk range through an at-home saliva test. If the elevated risk is detected, couples may choose their options to protect their future child's health, monitor biomarkers, adapt diet or elect for IVF. Orchid's Embryo Report will enable couples pursuing IVF and their physicians to implant embryos in the order that mitigates disease risk.

## Funding rounds

- Seed, Apr 7, 2021, $4.5M — Olive Capital, Stellar, Eventbrite, Inc., 23andMe, Inc., Coinbase Global, Inc., Flatiron Health, Inc., Counsyl Inc., Oscar Insurance Corporation, Clover Health Inc., Refactor Capital, Boom Capital Management, Village Global, Day One Ventures

## Investors

- Olive Capital — Seed
- Stellar — Seed
- Eventbrite, Inc. — Seed
- 23andMe, Inc. — Seed
- Coinbase Global, Inc. — Seed
- Flatiron Health, Inc. — Seed
- Counsyl Inc. — Seed
- Oscar Insurance Corporation — Seed
- Clover Health Inc. — Seed
- Refactor Capital (https://capitalatlas.ai/funds/refactor-capital) — Seed
- Boom Capital Management (https://capitalatlas.ai/funds/boom-capital-management) — Seed
- Village Global (https://capitalatlas.ai/funds/village-global) — Seed
- Day One Ventures (https://capitalatlas.ai/funds/day-one-ventures) — Seed